Enter assignee name

EPO Patents = 3

Forward Citations = 8

Loading Chart...

8 inventors (with patents filed for the assignee):

Wolfgang Albrecht (6 out of 42 patents)

Roland Selig (6 out of 12 patents)

Stefan Laufer (6 out of 21 patents)

4. Phillip Klövekorn (2 out of 2 patents)

5. Bent Präfke (2 out of 2 patents)

6. Philip Klövekorn (2 out of 2 patents)

7. Bent Praefke (2 out of 2 patents)

8. Michael Juchum (1 out of 1 patent)

9. Philip KLÖVEKORN (0 patent)

6 patents: Sort by Forward Citations

1. 12466826 - 3-benzoyl-1H-pyrrolo[2,3-b]pyridine derivatives as MKK4 inhibitors for treating liver diseases (2025-11-11),

2. 12264158 - Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death (2025-04-01),

3. 11912701 - Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death (2024-02-27),

4. 11858927 - Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death (2024-01-02),

5. 11731968 - Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death (2023-08-22),

6. 11040027 - Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death (2021-06-22),

Heparegenix GmbH is a biotechnology company dedicated to developing innovative therapies for liver diseases. Our focus is on advancing therapeutic approaches for conditions such as chronic hepatitis, cirrhosis, and liver cancer. With a team of experienced scientists and clinicians, we are committed to improving the lives of patients worldwide through our groundbreaking research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

6 Patents

#22 in Ulm

#5,304 in Germany

Ulm, Germany

Heparegenix Gmbh